hukuda_bnr
FUKUDA, Haruhiko
Graduated from Kobe University School of Medicine in 1987. Engaged in clinical practice as a gastroenterologist/endoscopist for a total of nine years at Hyogo Prefectural Kaibara Hospital, National Cancer Center Hospital, and Kobe University Hospital. Became a staff physician at the National Cancer Center Hospital in 1995, and has been in charge of managing the JCOG Data Center since 1996. Became head of the Clinical Information Section at the National Cancer Center Research Institute in 1998, and director of the JCOG Data Center since 1999. Became chief of the Clinical Trials and Practice Support Division of the Center for Cancer Control and Information Service in 2006, and chief of the Data Management Division of the Clinical Research Support Office at the National Cancer Center Hospital in 2017 (current position). Specializes in clinical trial methodology.

We would like to promote DX (operational transformation through the use of digital technology)
in clinical research sites and expand our support to promising budding research.

Chief of Data Management Division, Clinical Research Support Office, National Cancer Center Hospital / Director, JCOG Data Center

We support various clinical trials conducted
by the Japan Clinical Oncology Group.

hukuda_img1

Cancer treatment involves three main modalities: drug therapy, surgical therapy, and radiotherapy. Many types of cancer are treated with “multimodal therapy,” combining at least two of the three modalities. The development of new drugs in drug therapy is typically driven by pharmaceutical companies, while the development of other treatment modalities is primarily initiated by investigators.
JCOG (Japan Clinical Oncology Group) is the organization that conducts multicenter clinical trials initiated by investigators to develop cancer treatments. JCOG consists of 16 specialized groups focused on solid tumor research for adults, with around 190 medical institutions and approximately 800 treatment departments involved.
JCOG continuously conducts around 100 clinical trials. JCOG has two central supporting entities: the JCOG Data Center and the JCOG Operations Office. These activities are managed and coordinated by the Clinical Research Support Office at the National Cancer Center Hospital. The JCOG Data Center and JCOG Operations Office support all processes, from planning and preparation of activation to publication of results, for cancer treatment development trials conducted by JCOG’s 16 specialized groups.

hukuda

Through The FUTURE Project,
we aim to promote DX at JCOG and enhance support capabilities.

JCOG conducts clinical trials for treatment development that are not conducted by pharmaceutical companies. About one-third of these trials focus on drug therapy, one-third on multimodal therapy, and one-fourth are surgery-only trials. Especially, JCOG conducts the largest number of clinical trials evaluating surgical techniques worldwide and has contributed to the development of evidence supporting the effectiveness of minimally invasive surgery.
Additionally, JCOG conducts a wide range of clinical trials on radiotherapy and endoscopic treatments. However, research focused on developing new treatment methods and implementing personalized treatment has not yet been fully carried out due to limited resources. The JCOG Data Center and JCOG Operations Office are operated by around 50 staff members from the National Cancer Center and the Clinical Oncology Research and Education (CORE), but increasing the workforce is currently a challenge. Therefore, we believe that promoting DX at the institutional level will enhance support capabilities by improving work efficiency.
Even if public research funds like AMED* are unavailable, treatment development can still progress, provided the funding is allocated to support promising and exploratory studies. Especially, we are hopeful that The FUTURE Project can be utilized in research areas that are unlikely to be covered by public research funds.

*AMED: Japan Agency for Medical Research and Development

Project Information

Multi-institutional clinical trials by JCOG (Japan Clinical Oncology Group)

JCOG (Japan Clinical Oncology Group) is an all-Japan, investigator- initiated , multi- institutional collaborative clinical trial project involving approximately 190 medical institutions across Japan. Around 100 clinical trials are currently being conducted, with over 400 papers published in various journals.

Read more

We need your support

We look forward
to your warm support!

Our goal is to improve medical care through the development of research infrastructure, support for young researchers, and enhanced patient and citizen involvement. Your donation will be carefully used for these activities and will lead to the future of many patients. We sincerely look forward to your support.

support_img_sp
Click here to make a donation